Abstract
This paper reviews the evolution of the Addiction Research Center Inventory (ARCI) into a viable instrument for determining the subjective effects of drugs. Primary focus is on item selection, scale development, the development of short forms for different objectives, and the use of the ARCI as a diagnostic tool. The importance of items and scales of euphoric content in the ARCI is highlighted.
The item selection process for both the 550 item inventory and the additional 50 items dealing with classical withdrawal symptoms is described. Discussion of scale development begins with the construction of the empirical scales which distinguished a given drug from placebo and continues through the development of drug-specific scales, those scales that can distinguish between drugs.
The clinical scales, which discriminate between groups, are briefly discussed with emphasis on the appropriate use of the psychopathology scales. In terms of test validity, the effective use which has been made of the drug orientated ARCI short forms and selected scales is discussed in some detail with relevant comment regarding the utility of the total ARCI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abramson, H. A., Jarvik, M. E., Kaufman, M. R., Kornetsky, C., Levine, A., & Wagner, M. (1955). Lysergic acid diethylamide (LSD-25): I. Physiological and perceptual responses. Journal of Psychology, 39, 3–60.
Angrist, B., & Gershon, S. (1979). Variable attenuation of amphetamine effects by lithium. American Journal of Psychiatry, 136, 806–810.
Angrist, B., Rotrosen, J., & Gershon, S. (1974). Assessment of tolerance to the hallucinogenic effects of DOM. Psychopharmaco 1 ogia, 36, 203–207.
Battig, K., & Fischer, H. (1965). Personlichkeitsmerkmale, subjectives Selbstempfinden und psychomotische Leistung unter Alkohol-einfklusz bei jungen, nicht Alkohol gewohnten Individuen. (The effects of alcohol on personality traits, subjective states and psychomotor performance in young subjects not used to the effects of alcohol.) Zeitschrift fur Praventivmedizin, 10, 386–396.
Battig, K., & Fischer, H. (1966). Haben rezeptfreie Analgetica und Placebos eine verschiedene Wirkung auf das subjektive Seibstempfinden, die Personlichkeitslage und die psychomotorische Leistung? (Have nonprescription analgesics and placebos a different action on subjective states, personality traits, and psychomotor performance?) Schweizerische Medizinische Wochenschrift, 96, 570–575.
Battig, K., & Fischer, H. (1967). Complete German translation of the Addiction Research Center Inventory. Obtainable from Dr. C. A. Haertzen, NIDA, Addiction Research Center, Francis Scott Key Medical Center, Bldg. C, 4940 Eastern Avenue, Baltimore, Maryland, 21224 or from Dr. K. Battig, Eidg. Technische Hochschule, Institut fur Hygiene und Arbeitsphysiologie, Clausiusstrasze 25 Zurich 6 Switzerland.
Battig, K., & Fischer, H. (1968). Die Suggerierbarkeit bei der psychischen Wirkung von Pharmaka. (Suggestibility in the psychological action of drugs.) Schweizerische Medizinische Wochenschrift, 98, 898–904.
Beecher, H. K. (1959). Measurement of subjective responses. New York: Oxford University Press.
Belleville, R. E. (1956). MMPI score changes induced by lysergic acid diethylamide. Journal of Clinical Psychology, 12, 279–282.
Bernick, N., Altman, F., & Mintz, D. L. (1972). Pupil responses of addicts in treatment to drug culture argot: II. Responses during verbalization of visually presented words. Psychonomic Science, 28, 81–82.
Biehl, B. (1979). Studies of clobazam and car-driving. British Journal of Clinical Pharmacology, 7, 85S-90S.
Biehl, B., Fuhrmann, J., & Seydel, U. (1969). Auswirkungen der gleichzeitigen Einnahme von Alkohol und vitaminhaltigen Fruchtsaften auf psychologische Testleistungen und die B1 ut alkohol konzentration. (The effect of simultaneous administration of alcohol and fruit juice containing vitamins on psychological test performance and blood alcohol levels.) Zeitschrift fur Experimentelle und Angewandte Psychologie, 16, 402–419.
Cameron, J. S., Specht, P. G., & Wendt, G. R. (1967). Effects of two meprobamate-amphetamine combinations on moods, emotions, and motivations. Journal of Psychology, 67, 169–181.
Cattell, R. B. (1952). Factor analysis. New York: Harper & Brothers.
Cattell, R. B. (1957). The Sixteen Personality Factor Questionnaire (rev. ed.). Champaign, IL: Institute for Personality and Ability Testing.
Clark, S. C., Jasinski, D. R., Pevnick, J. S., & Griffith, J. D. (1976). Azidomorphine: Subjective effects and suppression of morphine abstinence. Clinical Pharmacology and Therapeutics, 19, 295–299.
Clyde, D. J. (1960). Self ratings. In L. Uhr & G. Miller (Eds.), Drugs and behavior (pp. 583–586). New York: John Wiley & Sons.
Cole, J. O., Orzack, M. H., Beake, B., Bird, M., & Bartal, Y. (1982). Assessment of the abuse liability of buspirone in recreational sedative users. Journal of Clinical Psychiatry, 43, 69–75.
Cole, J. O., Pope, H. G., LaBrie, R., & Ionescu-Pioggia (1978). Assessing the subjective effects of stimulants in casual users. Clinical Pharmacology and Therapeutics, 24, 243–252.
Colpaert, F. C. (1978). Theoretical review: Discriminative stimulus properties of analgesic drugs. Pharmacology Biochemistry & Behavior, 5, 401–408.
Cowan, J. D., Kay, D. C., Neidert, G. L., Ross, F. E., & Belmore, S. M. Drug abusers: Defeated and joyless. In L. S. Harris (Ed.), Problems of drug dependence. 1979 (National Institute on Drug Abuse Research Monograph 27, pp. 170–176). Washington, DC: U.S. Government Printing Office.
Cowan, J. D., Kay, D. C., Neidert, G. L., Ross, F. E., & Belmore, S. M. (1981) Defeated and joyless: Potential measures of change in drug abuser characteristics. Journal of Nervous and Mental Disease, 168, 391–399.
Datel, W. E., Gieseking, C. F., Engle, E. 0., & Dougher, M. J. (1966). Affect levels in a platoon of basic trainees. Psychological Reports, 18, 271–285.
Davis, K. E., Evans, W. O., & Gillis, J. S. (1 968). The effects of amphetamine and chlorpromazine on cognitive skills and feelings in normal adult males. In W. O. Evans & N. S. Kline (Eds.), The psychopharmacology of the normal human (pp. 126–161). Springfield, IL: Charles C. Thomas. (Also as report #92, Institute of Behavioral Science, University of Colorado, June 1967.)
de Wit, H., Johanson, C. E., McCracken, S., & Uhlenhuth, E. H. (1983). The effects of two non-pharmacological variables on drug preference in humans. In L. S. Harris (Ed.), Problems of drug dependence, 1982 (National Institute on Drug Abuse Research Monograph 43, pp. 251–257). Washington, DC: U.S. Government Printing Office.
de Wit, H., Johanson, C. E., & Uhlenhuth, E. H. (1983, June). Comparison of subjects who consistently chose amphetamine (Choosers, N =11) and subjects who consistently chose placebo (non-choosers, N = 11). Presented at the meeting of the Committee on Problems of Drug Dependence, Lexington, KY.
de Wit, H., Johanson, C. E., & Uhlenhuth, E. H. (1984). Drug preference in humans: Lorazepam. In L. S. Harris (Ed.), Problems of drug dependence, 1983 (National Institute on Drug Abuse Monograph 49, pp. 227–232). Washington, DC: U.S. Government Printing Office.
Ehlers, T. (1966). Alkoholbedingte Motivationsanderungen und Unfallgefahrdung. (Alcohol induced motivational changes and accident proneness.) Zeitschrift fur Experimentelle und Angewandte Psychologie, 13, 1–18.
Eisenberg, H. A. (1983). A cross-reference to the Addiction Research Center Inventory. Mimeographed, Portland State University, Portland, OR.
Eisenberg, H. A. (1974). Scale membership and scoring for the Addiction Research Center Inventory. Mimeographed, Portland State University, Portland, OR.
Evans, M., Chadd, M. A., Evans, C. M., Fry, D. M., & Robson, P. J. (1983). Administration of meptazinol to opiate-dependent patients. Postgraduate Medical Journal, 59, 78–84.
Eysenck, H. K. (1950). Criterion analysis––An application of the hypothetico deductive method to factor analysis. Psychological Review, 57, 38–53.
Eysenck, H. K. (1957). The dynamics of anxiety and hysteria. New York: Frederick A. P. Praeger.
Fabian, W. D., & Fishkin, S. M. (1982). Attentional absorption in marijuana and alcohol intoxication. Submitted to the American Psychological Association. Reference paper: Fabian, W. D., Jr. & Fishkin, S. M. (1981). A replicated study of self-reported changes in psychological absorption with marijuana intoxication. Journal of Abnormal Psychology, 6, 546–553.
Feinberg, M., Pegeron, J. P., & Steiner, M. (1983). The effect of morphine on symptoms of endogenous depression. In L. S. Harris (Ed.), Problems of drug dependence, 1982 (National Institute on Drug Abuse Research Monograph 34, pp. 245–250). Washington, DC: U.S. Government Printing Office.
Fischman, M. W., & Schuster, C. R. (1980). Cocaine effects in sleep deprived humans. Psychopharmacology, 72, 1–8.
Fischman, M. W., & Schuster, C. R. (1981). Acute tolerance to cocaine in humans. In L. S. Harris (Ed.), Problems of drug dependence, 1980 (National Institute on Drug Abuse Research Monograph 34, pp. 241–242). Washington, DC: U.S. Government Printing Office.
Fischman, M. W., Schuster, C. R., & Rajfer, S. (1983). A comparison of the subjective and cardiovascular effects of cocaine and procaine in humans. Pharmacology Biochemistry & Behavior, 18, 711–716.
Fischman, M. W., Schuster, C. R., Resnekov, L., Krasnegor, N. A., Schick, J. F. E, Fennell, W., & Freedman, D. X. (1976). Cardiovascular and subjective effects of intravenous cocaine administration in humans. Archives of General Psychiatry, 33, 983–989.
Fraser, H. F., & Jasinski, D. R. (1977). The assessment of the abuse potentiality of sedative/hypnotics (depressants): Methods used in animals and man. In W. R. Martin (Ed.), Drug addiction I: Morphine, sedative/hypnotic and alcohol dependence (pp. 589–612). New York: Springer-Verlag.
Fraser, H. F., Kay, D. C., Gorodetzky, C. W., Yeh, S. Y., & Dewey, W. L. (1978). Evidence for the importance of n-dealkylation in opioid pharmacology. Drug and Alcohol Dependence, 3, 1–22.
Fruchter, B. (1954) Introduction of factor analysis. New York: D. Van Nostrand.
Gold, M. S., Pottash, A. L. C., Sweeney, D. R., & Kleber, H. D. (1979). Clonidine detoxification: A fourteen-day protocol for rapid opiate withdrawal. In L. S. Harris (Ed.), Problems of drug dependence, 1979 (National Institute on Drug Abuse Research Monograph 27, pp. 226–232). Washington, DC: U.S. Government Printing Office.
Gold, M. S., Pottash, A. L. C., Sweeney, D. R., & Kleber, H. D. (1980a). Efficacy of clonidine in opiate withdrawal: A study of thirty patients. Drug and alcohol dependence, 6, 201–208.
Gold, M. S., Pottash, A. L. C., Sweeney, D. R., & Kleber, H. D. (1980b). Opiate withdrawal using clonidine. Journal of the American Medical Association, 243, 343–346.
Gough, H. G. (1954). Some common misconceptions about neuroticism. Journal of Consulting Psychology, 18, 287–292.
Gough, H. G. (1957). California Psychological Inventory Manual. Palo Alto, CA: Consulting Psychologist Press.
Griffith, J. D., Carranza, J., Griffith, C., & Miller, L., (1983). A comparison of bupropion and amphetamine for abuse liability. In L. S. Harris (Ed.), Problems of Drug Dependence, 1982 (National Institute on Drug Abuse Monograph 43, pp. 373). Washington, DC: U.S. Government Printing Office.
Griffiths, R. R., & Balster, R. L. (1979). Opioids: Similarity between evaluations of subjective effects and animal self-administration results. Journal of Pharmacology and Therapeutics, 25, 611–617.
Griffiths, R. R., Bigelow, G. E., & Liebson, I. A. (1981). Human preference comparison of pentobarbital, diazepam, and placebo. In L. S. Harris (Ed.), Problems of drug dependence, 1980 (National Institute on Drug Abuse Research Monograph 34, pp. 220–225). Washington, DC: U.S. Government Printing Office.
Griffiths, R. R., Bigelow, G. E., & Liebson, I. A. (1983). Differential effects of diazepam and pentobarbital on mood and behavior. Archives of General Psychiatry, 40, 865–873.
Griffiths, R. R., Bigelow, G. E., Liebson, I. A., & Kaliszak, J. E. (1980). Drug preference in humans: Double-blind choice comparison of pentobarbital, diazepam and placebo. Journal of Pharmacology and Experimental Therapeutics, 215, 649–661.
Gritz, E. R., Schiffman, S. M., Jarvik, M. E., Schlesinger, J., & Charuvastra, V. C. (1976). Naltrexone: Physiological and psychological effects of single doses. Clinical Pharmacology and Therapeutics, 19, 773–776.
Guelfi, J. D., Brun, J. P., & Dreyfus, J. F. (1983). French Translation of Addiction Research Center Inventory (ARCI). Paris: Therapharm Recherches.
Guilford, J. P., & Zimmerman, W. S. (1949). The Guilford-Zimmerman Temperament Survey. Beverly Hills, CA: Sheridan Supply.
Haddox, V. G., Jacobson, M. D., & Selden, R. W. (1972). Development of an instrument for assessing addict rehabilitation success. Paper presented at the meeting of the American Psychological Association.
Haertzen, C. A. (1961). A test of a basic assumption of causation in factor analytic theory: Changes in correlation between responses and changes in factor composition following the administration of LSD. Unpublished doctoral dissertation, University of Kentucky.
Haertzen, C. A. (1962). Criterion analysis of seven drug scales. Paper presented at the meeting of the Midwestern Psychological Association, Chicago.
Haertzen, C. A. (1963a). An Appendix of Addiction Research Center Inventory (ARCI) Scales: Temporary Report. NIMH Addiction Research Center, Lexington, KY.
Haertzen, C. A. (1963b). Method for direct determination of inverted factor loadings. Psychological Reports, 12, 399–402.
Haertzen, C. A. (1964). On the Addiction Research Center Inventory scores of former addicts receiving LSD, and untreated schizophrenics. Psychological Reports, 14, 483–488.
Haertzen, C. A. (1965a). Addiction Research Center Inventory (ARCI): Development of a general drug estimation scale. Journal of Nervous and Mental Diseases, 141, 300–307.
Haertzen, C. A. (1965b). Subjective drug effects: A factorial representation of subjective drug effects on the Addiction Research Center Inventory. Journal of Nervous and Mental Diseases, 140, 280–289.
Haertzen, C. A. (1966a). Changes in correlation between responses to items of the Addiction Research Center Inventory produced by LSD-25. Journal of P sychopharmaco 1 ogy, 1, 27–36.
Haertzen, C. A. (1966b). Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychological Reports, 18, 163–194.
Haertzen, C. A. (1969a). Contrast effect on subjective experience in drug experiments. Psychological Reports, 24, 69–70.
Haertzen, C. A. (1969b). Implications of Eysenck’s criterion analysis for test construction: Is the MMPI Schizophrenia scale a criterion for schizophrenia? Psychological Reports, 24, 3.
Haertzen, C. A. (1970). Subjective effects of narcotic antagonists. Cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI). Psychopharmaco1 og i a, 18, 366–377.
Haertzen, C. A. (1974a). An overview of Addiction Research Center Inventory scales (ARCI): An appendix and manual of scales (DHEW Publication No. (ADM) 74–92). Rockville, MD: National Institute on Drug Abuse.
Haertzen, C. A. (1974b). Subjective effects of narcotic antagonists. In M. C. Braude, L. S. Harris, E. L. May, J. P. Smith & J. E. Villarreal (Eds.), Narcotic antagonists (pp. 383–398). New York: Raven Press.
Haertzen, C. A. (1978). Clinical psychological studies. In W. R. Martin, & H. Isbell (Eds.), Drug addiction and the U. S. Public Health Service, DHEW Publication No. (ADM) 77–434, (pp. 155–168). Rockville, MD: National Institute of Drug Abuse.
Haertzen, C. A. (1983). Measurement of subjective drug effects with the Addiction Research Center Inventory. Paper presented in a symposium held by The American Psychological Association, Anaheim, CA.
Haertzen, C. A., & Fuller, G. (1967). Subjective effects of acute withdrawal of alcohol as measured by the Addiction Research Center Inventory (ARCI). Quarterly Journal of Studies on Alcohol, 28, 454–467.
Haertzen, C. A., & Hill, H. E. (1959). Effects of morphine and pentobarbital on differential MMPI profiles. Journal of Clinical Psychology, 15, 434–437.
Haertzen, C. A., & Hill, H. E. (1963). Assessing subjective effects of drugs: An index of carelessness and confusion for use with the Addiction Research Center Inventory (ARCI). Journal of Clinical Psychology, 19, 407–412.
Haertzen, C. A., Hill, H. E., & Belleville, R. E. (1963). Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs. Psychopharmaco 1 ogia, 4, 155–166.
Haertzen, C. A., Hill, H. E, & Monroe, J. J. (1968). MMPI scales for differentiating and predicting relapse in alcoholics, opiate addicts and criminals. International Journal of the Addictions, 3, 91–106.
Haertzen, C. A., & Hooks, N. T., Jr. (1968). Effects of adaptation level, context and face validity on responses to self-report psychological inventories. Psychological Record, 18, 339–349.
Haertzen, C. A., & Hooks, N. T., Jr. (1969). Changes in personality (MMPI) and subjective experience (ARCI) throughout a cycle of addiction to morphine. Journal of Nervous and Mental Disease, 148, 606–614.
Haertzen, C. A., & Hooks, N. T., Jr. (1971). Contrast effects from simulation or subjective experiences: A possible standard for behavioral modification. British Journal of Addiction, 66, 225–227.
Haertzen, C. A., & Hooks, N. T., Jr. (1973). Dictionary of drug associations to heroin, Benzedrine, alcohol, barbiturates, and marijuana. Journal of Clinical Psychology, 29, 115–164.
Haertzen, C. A., Hooks, N. T., Jr., & Hill, H. E. (1966, December). Prediction of subjective responses to drugs. Proceedings of the American College of Neuropsychopharmacology, San Juan, Puerto Rico.
Haertzen, C. A., Hooks, N. T., Jr., & Pross, M. (1974). Drug associations as a measure of habit strength for specific drugs. Journal of Nervous and Mental Disease, 158, 189–197.
Haertzen, C. A., Long, R., & Philip, P. (1964, November). A survey of mental hospital patients on the Addiction Research Center Inventory (ARCI): A comparison of post addicts and mental patients. Paper presented at the meeting of the Kentucky Psychological Association, Louisville, KY.
Haertzen, C. A., Martin, W. R., Hewett, B. B., & Sandquist, V. (1978). Measurement of psychopathy as a state. Journal of Psychology, 100, 201–214.
Haertzen, C. A., Martin, W. R., Ross, F. E., & Neidert, G. L. (1980). Psychopathic State Inventory (PSI): Development of a short test for measuring psychopathic states. International Journal of the Addictions, 15, 137–146.
Haertzen, C. A., & Meketon, M. J. (1968). Opiate withdrawal as measured by the Addiction Research Center Inventory (ARCI). Diseases of the Nervous System, 29, 450–455.
Haertzen, C. A., Meketon, M. J., & Hooks, N. T., Jr. (1970). Subjective experiences produced by the withdrawal of opiates. British Journal of Addiction, 65, 245–255.
Haertzen, C. A., & Miner, E. J. (1965). Effect of alcohol on the Guilford-Zimmerman scales of extraversion. Journal of Personality and Social Psychology, 1, 333–336.
Haertzen, C. A., & Panton, J. (1967). Development of a “psychopathic” scale for the Addiction Research Center Inventory (ARCI). International Journal of the Addictions, 2, 115–127.
Haertzen, C. A., Fuller, G., Hooks, N. T., Jr., Monroe, J. J., & Sharp, H. (1968). Nonsignificance of membership in Alcoholics Anonymous in hospitalized alcoholics. Journal of Clinical Psychology, 24, 99–103.
Haertzen, C. A., Hill, H. E., Wikler, A., & Wolbach, A. B. (1961). Evaluating subjective effects of six drugs by means of an especially designed inventory. Paper presented at the meeting of the Midwestern Psychological Association, Chicago.
Hathaway, S. R., & McKinley, J. C. (1951). Minnesota Multiphasic Personality Inventory manual (Rev. Ed.). New York: Psychological Corporation.
Henningfield, J. E., Chait, L. D., & Griffiths, R. R. (1983). Cigarette smoking and subjective response in alcoholics: Effects of pentobarbital. Clinical Pharmacology and Therapeutics, 33, 806–812.
Henningfield, J. E., Chait, L. D., & Griffiths, R. R. (1984). Effects of ethanol on cigarette smoking by volunteers without histories of alcoholism. Psychopharmacologia, 82, 1–5.
Henningfield, J. E., & Griffiths, R. R. (1981). Cigarette smoking and subjective response: Effects of d-amphetamine. Clinical Pharmacology and Therapeutics, 30, 497–505.
Hill, H. E., Haertzen, C. A., & Belleville, R. E. (1958). The Addiction Research Center Inventory (ARCI) Test Booklet. Lexington, KY: NIMH Addiction Research Center.
Hill, H. E., Haertzen, C. S., & Glaser, R. (1960). Personality characteristics of of narcotic addicts as indicated by the MMPI. Journal of General Psychology, 62, 127–139.
Hill, H. E., Haertzen, C. A., Wolbach, A. B., & Miner, E. J. (1963a). The Addiction Research Center Inventory: Appendix I. Items comprising empirical scales for seven drugs. II. Items which do not differentiate placebo from any drug condition. Psychopharmaco1ogia, 4, 184–205.
Hill, H. E., Haertzen, C. A., Wolbach, A. B., & Miner, E. J. (1963b). The Addiction Research Center Inventory: Standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol, LSD-25, pyrahexyl and chlorpromazine. Psychopharmacologia, 4, 167–183.
Himmelsbach, C. K. (1941). The morphine abstinence syndrome, its nature and treatment. Annals of Internal Medicine, 15, 829–839.
Hoch, P. E., & Solomon, G. (1952). Experimental induction of psychosis. In P. B. Cobb (Ed.), The biology of mental health and disease (pp. 539–547). New York: Harper & Brothers.
Hollister, L. E., & Gillespie, H. K. (1973). Delta-8- and delta-9-tetrahydrocannabinol: Comparison in man by oral and intravenous administration. Clinical Pharmacology and Therapeutics, 14, 353–357.
Hollister, L. E., & Gillespie, H. K. (1975). Action of delta-9-tetrahydrocannabinol. Clinical Pharmacology and Therapeutics, 18, 714–719.
Hollister, L. E., Overall, J. E., & Gerber, M. L. (1975). Marijuana and setting. Archives of General Psychiatry, 32, 798–801.
Isbell, H. (1956). Attempted addiction to nalorphine. Federation Proceedings, 1, 442.
Isbell, H., Belleville, R. E., Fraser, H. F., Wikler, A. & Logan, C. R. (1956). Studies on lysergic acid diethylamide: I. Effects in former morphine addicts and development of tolerance during chronic intoxication. Archives of Neurology and Psychiatry, 76, 468–478.
Isbell, H., Fraser, H. F., Wikler, A., Belleville, R. E., & Eisenman, A. J. (1955). An experimental study of the etiology of “rum fits” and delirium tremens. Quarterly Journal Studies Alcohol, 16, 1–33.
Isbell, H., Gorodetzky, C. W., Jasinski, D. R., Claussen, U., Spulak, F. V., & Korte, F. (1967). Effects of (-)-Δ9-Transtetrahydrocannabinol in man. Psychopharmaco1ogia, 11, 184–188.
Isbell, H., & Jasinski, D. R. (1969). A comparison of LSD-25 with (-)-Δ9-Transtetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC. Psychopharmacologia, 14, 115–123.
Jaffe, J. H., Kanzler, M., & Green, J. (1981). Abuse potential of loperamide: Adaptation of established evaluative methods to volunteer subjects. In L. S. Harris (Ed.), Problems of Drug Dependence, 1980 (National Institute on Drug Abuse Research Monograph 34, pp. 232–240). Washington, DC: U.S. Government Printing Office.
Jaffe, J. H., Schuster, C. R., Smith, C. R., & Blachley, P. H. (1970). Comparison of acetylmethadol and methadone in the treatment of long-term users. Journal of the American Medical Association, 211, 1834–1836.
Jasinski, D. R. (1973). Assessment of the dependence liability of opiates and sedative hypnotics. In L. Goldberg & F. Hoffmeister (Eds.), Bayer-Symposium IV-Psychic Dependence (pp. 160–170). New York: Springer-Verlag.
Jasinski, D. R. (1974). Narcotic antagonists as analgesics of low dependence liability-theoretical and practical implications of recent studies. In Yearbook of drug abuse (pp. 37–48). New York: Behavioral Publications.
Jasinski, D. R. (1977). Assessment of the abuse potentiality of morphine like drugs (methods used in man). In W. R. Martin (Ed.), Drug addiction I: Morphine, sedative/hypnotic and alcohol dependence (pp. 197–258). New York: Springer-Verlag.
Jasinski, D. R. (1982). Buprenorphine as a pharmacologic treatment modality for narcotic addicts. Presented in a symposium on buprenorphine held by the American Society for Pharmacology and Experimental Therapeutics, Louisville, Kentucky, August 1982. The Pharmacologist, 24, 89.
Jasinski, D. R., Carr, C. B., & Griffith, J. D. (1975). Etorphine in man. 1. Subjective effects and suppression of morphine abstinence. Clinical Pharmacology and Therapeutics, 17, 267–272.
Jasinski, D. R., Carr, C. B., Gorodetzky, C. W., Griffith, J. D., &Kullberg, M. P. (1974). Progress report from the clinical pharmacology section of the Addiction Research Center. Committee on problems of Drug Dependence, 88–115. Springfield, VA: National Technical Information Service.
Jasinski, D. R., Haertzen, C. A., Henningfield, J. E., Johnson, R. E., Makhzoumi, H. M., & Miyasato, K. (1982). Progress Report of the NIDA Addiction Research Center. In L. S. Harris (Ed.), Problems of drug dependence, 1981 (National Institute on Drug Abuse Research Monograph 41, pp. 45–52). Washington, DC: U.S. Government Printing Office.
Jasinski, D. R., Haertzen, C. A., & Isbell, H. (1971). Review of the effects in man of marijuana and tetrahydrocannabinols on subjective state and physiologic functioning. Annals of the New York Academy of Sciences, 191, 196–205.
Jasinski, D. R., Henningfield, J. E., Hickey, J. E., & Johnson, R. E. (1983). Progress report of the National Institute on Drug Abuse Addiction Research Center, 1982. In L. S. Harris (Ed.), Problems of drug dependence, 1982. (National Institute on Drug Abuse Research Monograph 43, pp. 92–98). Washington, DC: U.S. Government Printing Office.
Jasinski, D. R., & Johnson, R. E. Abuse potential of chlordiazepoxide. The Pharmacologist, 132, 24, 133.
Jasinski, D. R., & Mansky, P. A. (1972). Evaluation of nalbuphine for abuse potential. Clinical Pharmacology and Therapeutics, 13, 78–90.
Jasinski, D. R., Martin, W. R., & Haertzen, C. A. (1 967). The human pharmacology and abuse potential of N-al1ylnoroxymorphone (naloxone). Journal of Pharmacology and Experimental Therapeutics, 157, 420–426.
Jasinski, D. R., Martin, W. R., Hoeldtke, R. D. (1970). Effects of short-and long-term administration of pentazocine in man. Clinical Pharmacology and Therapeutics, 11, 385–403.
Jasinski, D. R., Martin, W. R., & Hoeldtke, R. D. (1971). Studies of the dependence-producing properties of GPA-1657, profadol, and propiram in man. Clinical Pharmacology and Therapeutics, 12, 613–649.
Jasinski, D. R., Martin, W. R., & Sapira, J. D. (1968a). Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone. Clinical Pharmacology and Therapeutics, 9, 215–222.
Jasinski, D. R., Martin, W. R., & Sapira, J. D. (1968b). Progress report on the dependence-producing properties of GPA-1 657, profadol hydrochloride (CI-572), propiram fumarate (Bay-4503) and dexoxadral. Paper presented at 30th meeting, Committee on Problems of Drug Dependence, Indianapolis.
Jasinski, D. R., Nutt, J. G., & Griffith, J. D. (1974). Effects of diethylpropion and d-amphetamine after subcutaneous and oral administration. Clinical Pharmacology and Therapeutics, 16, 645–652.
Jasinski, D. R., Nutt, J. G., Haertzen, C. A., Griffith, J. D., & Bunney, W. E. (1977). Lithium: Effects on subjective functioning and morphine-induced euphoria. Science, 195, 582–584.
Jasinski, D. R., Clark, S. C., Griffith, J. D., & Pevnick, J. S. (1977). Therapeutic usefulness of propoxyphene napsylate in narcotic addiction. Archives of General Psychiatry, 34, 227–233.
Jasinski, D. R., Pevnick, J. S., & Griffith, J. D. (1978). Human pharmacology and abuse potential of the analgesic buprenorphine. Archives of General Psychiatry, 35, 501–516.
Johnson, R. E., & Jasinski, D. R. (1982). Abuse potential of zomepirac. Paper presented at American Society for Pharmacology and Experimental Therapeutics, Louisville, KY.
Johnson, R. E., Jasinski, D. R., & Kocher, T. R. (1983). Abuse potential of zomepirac (Zomac)R. Journal of Clinical Pharmacology and Therapeutics, 34, 386–389.
Kay, D. C. (1980). The search for psychopathic states in alcoholics and other drug abusers. In W. E. Fenn (Ed.), Phenomenology and treatment of alcoholism, (pp. 269–304). Jamaica, NY: Spectrum Publications.
Kiplinger, G. F., Manno, J. E., Rodda, B. E., & Forney, R. B. (1971). Dose-response analysis of the effects of tetrahydrocannabinol in man. Clinical Pharmacology and Therapeutics, 12, 650–657.
Kleber, H. D., Gold, M. S., & Riordan, C. E. (1980). The use of clonidine in detoxification from opiates. Bulletin on Narcotics, 32, 1–10.
Kolb, L. (1925). Pleasure and deterioration from narcotic addiction. Mental Hygiene, 9, 699–724.
Manno, J. L. (1970). Clinical investigations with marihuana and alcohol, unpublished doctoral dissertation, University of Indiana.
Martin, W. R. (1966). Assessment of the dependence producing potentiality of narcotic analgesics. In C. Radouco-Thomas & L. Lasagna (Eds.), International encyclopedia of pharmacology and therapeutics (Vol. 1, pp. 155–180). Glasgow: Pergamon Press.
Martin, W. R. (1967). Clinical evaluation for narcotic dependence. In New Concepts in pain and its clinical management. Philadelphia: F. A. Davis.
Martin, W. R. (1973). Assessment of the abuse-potential ity of amphetamines and LSD-like hallucinogens in man and its relationship to basic animal assessment programs. In L. Goldberg & F. Hoffmeister (Eds.), Bayer-Symposium IV, psychic dependence (pp. 146–155). New York: Springer-Verlag.
Martin, W. R. (1974). Drug abuse––the need for a rational pharmacologic approach. In Yearbook of drug abuse (pp. 1–15). New York: Behavioral Publications.
Martin, W. R., & Fraser, H. F. (1961). A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postàddicts. Journal of Pharmacology and Experimental Therapeutics, 133, 388–399.
Martin, W. R., Fraser, H. F., Gorodetzky, C. W., & Rosenberg, D. E. (1965). Studies of the dependence-producing potential of the narcotic antagonist 2-cye1opropy1methy1–2’hydroxy-5, 9-dimethy1–6, 7-benzomorphan (cyclazocine, WIN-20, 740, ARC II-C-3. Journal of Pharmacology and Experimental Therapeutics, 15, 426–436.
Martin, W. R., Hewett, B. B., Baker, A. J., & Haertzen, C. A. (1977). Aspects of the psychopathology and pathophysiology of addiction. Drug and Alcohol Dependence, 2, 185–202.
Martin, W. R., Jasinski, D. R., Haertzen, C. A., Kay, D. C., Jones, B. E., Mansky, P. A., & Carpenter, R. W. (1973a). Methadone––a reevaluation. Archives of General Psychiatry, 28, 286–295.
Martin, W. R., Jasinski, D. R., & Mansky, P. A. (1973b). Naltrexone, an antagonist for the treatment of heroin dependence. Archives of General Psychiatry, 28, 784–791.
Martin, W. R., & Sloan, J. W. (1977). Pharmacology and classification of LSD-like hallucinogens. In W. R. Martin (Ed.), Drug addiction II (pp. 305–368). New York: Springer-Verlag.
Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971). Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245–258.
McCaul, M. E., Stitzer, M. L., Bigelow, G. E., & Liebson, I. A. (1981). Acute effects of oral methadone in methadone maintenance subjects. Paper presented at the American Psychological Association Convention held in Los Angeles, CA.
McCaul, M. E., Stitzer, M. L., Bigelow, G. E., & Liebson, I. A. (1982). Physiological and subjective effects of hydromorphone in postaddict volunteers. In L. S. Harris (Ed.), Problems of drug dependence, 1981 (National Institute on Drug Abuse Research Monograph 41, pp. 301–308). Washington, DC: U.S. Government Printing Office.
McCaul, M. E., Stitzer, M. L., Bigelow, G. E., & Liebson, I. A. (1983). Intravenous hydromorphone: Effects in opiate-free and methadone maintenance subjects. In L. S. Harris (Ed.), Problems of drug dependence, 1982 (National Institute on Drug Abuse Research Monograph 43, pp. 238–244). Washington, DC: U.S. Government Printing Office.
McClane, T. K., & Martin, W. R. (1976). Subjective and physiologic effects of morphine, pentobarbital, and meprobamate. Clinical Pharmacology and Therapeutics, 20, 192–198.
McLeod, D. R., Bigelow, G. E., & Liebson, I. A. (1982). Self-regulated opioid detoxification by humans: Effects of methadone pretreatment. In L. S. Harris (Ed.), Problems of drug dependence, 1981 (National Institute on Drug Abuse Research Monograph 41, pp. 232–238). Washington, DC: U.S. Government Printing Office.
McNair, D. M., Lorr, M., & Droppelman, L. F. (1971). EITS Manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Service.
Meketon, M. J. (1967). Exploring motivation within a total institution for drug addicts. Unpublished doctoral dissertation, University of Kentucky.
Meketon, M. J., & Perea, E. (1967). Partial Spanish translation of the Addiction Research Center Inventory. Lexington, KY.
Meyer, R. E., Altman, J. L., McNamee, B., & Mirin, S. M. (1976). A behavioral paradigm for the evaluation of narcotic antagonists. Archives of General Psychiatry, 33, 371–377.
Miller, L., & Griffith, J. (1983). A Comparison of bupropion, dextroamphetamine, and placebo in mi xe d — substance abusers. Psychopharmaco1ogy, 80, 199–205.
Nakano, S., Gillespie, H. K., Hollister, L. E. (1978). A model for evaluation of antianxiety drugs with the use of experimentally induced stress: Comparison of nabilone and diazepam. Clinical Pharmacology and Therapeutics, 23, 54–62.
Nowlis, V., & Nowlis, H. H. (1956). Description and analysis of mood. Annals of the New York Academy of Science, 65, 345–355.
Nutt, J. G., & Jasinski, D. R. (1974). Methadone-naloxone mixtures for use in methadone maintenance programs: I. An evaluation in man of their pharmacological feasibility; II. Demonstration of acute physical dependence. Clinical Pharmacology and Therapeutics, 15, 156–166.
O’Brien, C. P., & Minn, F. L. (1980). Evaluation of withdrawal symptoms following zomepirac administration. Journal of Clinical Pharmacology, 20, 397–400.
Orzack, M. H., Cole, J. L., Ionescu-Pioggia, Beake, B. J., Bird, M. P., Lobel, M., & Martin, M. D. (1982). A comparison of some subjective effects of prazepam, diazepam and placebo. In L. S. Harris (Ed.), Problems of drug dependence, 1981 (National Institute on Drug Abuse Research Monograph 41, pp. 309–317). Washington, DC: U.S. Government Printing Office.
Ottomanelli, G. A. (1973). The MMPI as a predictor of outcome in a methadone maintenance program. Unpublished doctoral dissertation, School of Education, New York University.
Ottomanelli, G. A. (1977). MMPI and Pyp prediction compared to base rate prediction of six-month behavioral outcome for methadone patients. British Journal of Addictions, 72, 177–186.
Ottomanelli, G. A. (1978). Patient improvement, measured by the MMPI and Pyp, related to paraprofessional and professional counselor assignment. International Journal of the Addictions, 13, 503–507.
Ottomanelli, G. A., & Halloran, G. (1982). Patient expectations and participation in a polydrug treatment program: A replicated field study. International Journal of the Addictions, 17, 1289–1311.
Overton, D. A., & Batta, S. K. (1979). Investigation of narcotics and antitussives using drug discrimination techniques. Journal of Pharmacology and Experimental Therapeutics, 211, 401–408.
Pevnick, J. S. (1981). Abuse of pentazocine (P) combined with tripelennamine (T): An interaction of psychopharmacological and societal factors. Federation of American Societies of Experimental Biology.
Pevnick, J. S., Haertzen, C. A., & Jasinski, D. R. (1978). Abrupt withdrawal from therapeutically administered diazepam. Archives of General Psychiatry, 35, 995–998.
Pichot, P. (1964). French Translation of the Addiction Research Center Inventory. NIMH Addiction Research Center. Can be obtained from Dr. Pichot at Hospital Sainte Anne, 1 Rue Canabnis, Paris (14) France.
Platt, J. J., & Labate, C. (1976). Heroin addiction theory, research and treatment. [Note: The book contains a review of the ARCI on pp. 331–336.] New York: John Wiley & Sons.
Resnick, R. B., Kestenbaum, R. S., & Schwartz, L. K. (1977). Acute systemic effects of cocaine in man: A controlled study by intranasal and intravenous routes. Science, 195, 696–698.
Rosenberg, D. E., Isbell, H., & Miner, E. J. (1963). Comparison of a placebo, N-dimethyl tryptami ne, and 6-hydr oxy-N-dimethyl tryptamine in man. Psychopharmaco1ogia, 4, 39–42.
Rosenberg, D. E., Isbell, H., Logan, C. R., & Miner, E. J. (1964). The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmaco1ogia, 5, 217–227.
Rosenberg, D. E., Wolbach, A. B., Miner, E. J., & Isbell, H. (1963). Observations on direct and cross tolerance with LSD and d-amphetamine in man. Psychopharmaco1ogia, 5, 1–15.
Savage, C. (1955). Variations in ego feeling induced by d-lysergic acid diethylamide (LSD-25). Psychoanalytic Review, 42, 1–16.
Schuster, C. R., Fischman, M. W., & Johanson, C. E. (1981). Internal stimulus control and subjective effects of drugs. In T. Thompson, & C. E. Johanson (Eds.), Behavioral pharmacology of human drug dependence. (National Institute on Drug Abuse Research Monograph 37, pp. 116–129). Washington, DC: U.S. Government Printing Office.
Shannon, H. E., & Holtzman, S. G. (1976). Evaluation of the discriminative effects of morphine in the rat. Journal of Pharmacology and Experimental Therapeutics, 198, 54–65.
Sharp, H., Fuller, G. B., & Haertzen, C. A. (1967). Acute alcohol withdrawal scales on the Addiction Research Center Inventory. Current Conclusions, July 11, 1–13.
Sice, J., Levin, J. J., Levine, H. D., & Haertzen, C. A. (1975). Effects of personal interactions and setting on subjective drug responses in small groups. Psychopharmac o1og ia, 43, 181–186.
Sideroff, S. I., & Jarvik, M. E. (1980). Conditioned responses to a videotape showing heroin-related stimuli. International Journal of the Addictions, 15, 529–536.
Sjoberg, L. (1969a). Alcohol and gambling. Psychopharmacologia, 14, 284–298.
Sjoberg, L. (1969b). A Swedish translation of the ARCI alcohol scale. Obtainable from L. Sjoberg, Universitetet i Stockholm, Drottninggatan 95 A, Stockholm VA Sweden.
Stitzer, M., Bigelow, G. E., & Liebson, I. A. (1981). Granting dose increases to methadone maintenance patients: Effects on symptomatology and drug use. In L. S. Harris (Ed.), Problems of drug dependence, 1980 (National Institute on Drug Abuse Research Monograph 34, pp. 387–393). Washington, DC: U.S. Government Printing Office.
Stitzer, M. L., Bigelow, G. E., & Liebson, I. A. (1982). Comparison of three outpatient methadone detoxification procedures. In L. S. Harris (Ed.), Problems of drug dependence, 1981 (National Institute on Drug Abuse Research Monograph 41, pp. 239–245). Washington, DC: U.S. Government Printing Office.
Stitzer, M. L., Griffiths, R. R., Bigelow, G. E., & Liebson, I. A. (1981). Human social conversation: Effects of ethanol, secobarbital and chlorpromazine. Pharmacology Biochemistry & Behavior, 14, 353–360.
Teasdale, J. D. (1973). Conditioned abstinence in narcotic addicts. International Journal of the Addictions, 8, 273–292.
Ternes, J. W., O’Brien, C. P., Grabowski, J., Wellerstein, H., & Jordan-Hayes, J., (1979). Conditioned drug responses to naturalistic stimuli. In L. S. Harris (Ed.), Problems of drug dependence, 1979 (National Institute on Drug Abuse Research Monograph 27, pp. 282–288). Washington, DC: U.S. Government Printing Office.
Thorndike, E. L., & Lorge, I. (1944). The teacher’s workbook of 30,000 words. New York: Bureau of Publications, Teacher’s College, Columbia University.
Toyama, P., & Heyder, C. (1981). Acupuncture induced mood changes reversed by the narcotic antagonist naloxone. Journal of Holistic Medicine, 3, 46–52.
Toyama, P. M., Popell, C., Evans, J., & Heyder, C. (1980). Acupuncture and moxibustion in the management of rheumatoid arthritis. Stress, 1, 19–24.
Uhlenhuth, E. H., Johanson, C. E., Kilgore, K., & Kobasa, S. C. (1981). Drug preference and mood in humans: Preference for d-amphetamine and subject characteristics. Psychopharmaco1ogy, 74, 191–194.
Van Dyke, C., Jatlow, P., Ungerer, J., Barash, P. G., & Byck, R. (1978). Oral cocaine: Plasma concentration and central effects. Science, 200, 211–213.
Watkins, D. C. (1972). The effects of hypnotic suggestions on the alcohol withdrawal syndrome. Unpublished doctoral dissertation, Temple University.
Wikler, A. (1964). Survey of research on alcohol at the National Institute of Mental Health, Addiction Research Center, In Proceedings of the 26th International Congress on alcohol and alcoholism, Stockholm, 1960. Stockholm: Swedish Congress Committee by Eklunds and Vasatryck.
Yanagita, T. Japanese Translation of selected ARCI Scales.
Yanagita, T., Inanaga, K., Kato, N., & Ueyama, M. (1980). Subjective effects of Afloqualone (HQ-495), a muscle relaxant, In healthy volunteers — A measure of psychological dependence-producing properties of drugs. Japanese Journal of Clinical Pharmacology and Therapeutics, 11, 181–195.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Haertzen, C.A., Hickey, J.E. (1987). Addiction Research Center Inventory (ARCI): Measurement of Euphoria and Other Drug Effects. In: Bozarth, M.A. (eds) Methods of Assessing the Reinforcing Properties of Abused Drugs. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4812-5_24
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4812-5_24
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-9163-3
Online ISBN: 978-1-4612-4812-5
eBook Packages: Springer Book Archive